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Background: Plasmodium falciparum has become resistant to some of the available drugs. Several plant species are
used for the treatment of malaria, such as Himatanthus articulatus in parts of Brazil. The present paper reports the
phyto-chemistry, the anti-plasmodial and anti-malarial activity, as well as the toxicity of H. articulatus.
Methods: Ethanol and dichloromethane extracts were obtained from the powder of stem barks of H. articulatus
and later fractionated and analysed. The anti-plasmodial activity was assessed against a chloroquine resistant strain
P. falciparum (W2) in vitro, whilst in vivo anti-malarial activity against Plasmodium berghei (ANKA strain) was tested in
mice, evaluating the role of oxidative stress (total antioxidant capacity - TEAC; lipid peroxidation – TBARS, and nitrites
and nitrates - NN). In addition, cytotoxicity was evaluated using the HepG2 A16 cell-line. The acute oral and sub-chronic
toxicity of the ethanol extract were evaluated in both male and female mice.
Results: Plumieride was isolated from the ethyl acetate fraction of ethanol extract, Only the dichloromethane extract
was active against clone W2. Nevertheless, both extracts reduced parasitaemia in P. berghei-infected mice. Besides, a
significant reduction in pulmonary and cerebral levels of NN (nitrites and nitrates) was found, as well as in pulmonary
TBARS, indicating a reduced oxidative damage to these organs. The ethanol extract showed low cytotoxicity to HepG2
A16 cells in the concentrations used. No significant changes were observed in the in vivo toxicity studies.
Conclusions: The ethanol extract of H. articulatus proved to be promising as anti-malarial medicine and showed
low toxicity.
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The World Malaria Report featured that 207 million
cases of malaria occurred worldwide in 2012 with
627.000 deaths [1]. Malaria is found in more than 100
countries, mainly in tropical regions of the world,
including Africa, Asia, Central and South America. In Brazil,
almost all cases occur in the Legal Amazon [2]. In Brazil,
between the years 2000 to 2011 there was a reduction in the* Correspondence: flavio@ufpa.br
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unless otherwise stated.number of malaria cases. In 2011 the number of reported
cases was 20% lower than previous years [3].
The first attempts for a specific treatment of malaria
date back to the early 18th century, with the use of
Cinchona tree bark; quinine was isolated as the active
ingredient in 1820 [4]. The extensive use of anti-malarial
drugs has imposed a tremendous selective pressure on the
parasites, leading to the emergence of resistance, particu-
larly in the case of Plasmodium falciparum [5]. Resistance
of P. falciparum to quinine was reported after 278 years of
clinical use, while for the majority of anti-malarial drugs,
such as proguanil, sulphadoxine-pyrimethamine and
atovaquone, resistance was reported much earlier; inis is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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described after only 10 years of clinical use [6].
New anti-malarial drugs are urgently needed. The candi-
date drugs ought to be active against both chloroquine-
and artemisinin-resistant P. falciparum strains. It should
provide a cure within a reasonable length of time (3
days or less), be safe, at low cost, and should be available
in an appropriate formulation for oral use [7].
Investigation of plant-derived compounds is a valid
strategy and this approach can take advantage from
traditional knowledge of native populations. Indeed,
natural products have yielded two of the most important
drugs used to treat falciparum malaria so far, quinine and
artemisinins [8]. Himatanthus articulatus is in popular use
in Brazil for the treatment of several diseases, including
skin infections, helminth infestations, gastric diseases, such
as peptic ulcers and gastritis [9], tumours [10], syphilis [11],
as a cough medicine [12], and as an anti-inflammatory and
analgesic [13]. It has been used against malaria [14,15], but
this activity does require validation studies.
Popularly known in Brazil as sucuuba, janaguba or
sucuba, H. articulatus is found in the South America,
including Panama, Colombia, Peru, Venezuela, Guyana,
Suriname, French Guyana and in the Brazilian Amazon and
the Atlantic Forest [12]. The species name H. articulatus
(Apocynaceae) is synonymous to Himatanthus rigidus,
Plumeria articulata Vahl, Plumeria drastica, Plumeria
microcalyx and Plumeria sucuuba [16,17]. It is a perennial,
heliophytic, selective, xerophytic and secondary plant that
inhabits sandy or mixed soils. Its trees can reach 10 to 20
metres in height, present substantial trunks and brokenFigure 1 Chemical structure of compouds occurring in Himatanthu
(D) isoplumericin, (E) lupeol cinnamate, (F) α-amyrin cinnamate, (G) β-amyrinbark, simple and alternate spiral leaves with glabrous
coriaceous and entire margins, white flowers of yellow
bell-shaped bases, phallic fruits, green colour when
immature and dark brown when mature [18].
Several iridoids have already been isolated from this spe-
cies: plumieride (Figure 1A), isoplumieride (Figure 1B), plu-
mericin (Figure 1C) and isoplumericin (Figure 1D). In
addition, also been isolated the triterpenes lupeol cinnamate
(Figure 1E), α-amyrin cinnamate (Figure 1F), β-amyrin cin-
namate (Figure 1G), and lupeol acetate (Figure 1H) [19,20].
Despite the broad popular use of H. articulatus bark
and latex for the treatment of malaria [9,10], and the
promising results described for terpenes [21,22], there is
a lack of validation of this activity for this species. A single
study has so far evaluated the anti-malarial activity against
a chloroquine sensitive clone of P. falciparum (3D7), with
no activity observed for the ethanol extract obtained from
the cortex [10].
The present study describes, for the first time, the
anti-plasmodial activity of H. articulatus against a chloro-
quine resistant clone of P. falciparum (W2), as well as the
anti-malarial activity in Plasmodium berghei-infected
mice. Moreover, it describes the results obtained in
phytochemical studies and cytotoxicity, acute oral and sub-
chronic toxicity. This study also reports changes in oxida-
tive stress caused in Plasmodium berghei-infected mice.
Methods
Plant material and phytochemical studies
Stem barks from H. articulatus were collected in Altamira
city, state of Pará, Brazil (S 01°10’86” W 41°53’51.6”), ins articulatus. (A) plumieride, (B) isoplumieride, (C) plumericin,
cinnamate, (H) lupeol acetate.
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in the Museum Paraense Emilio Goeldi (voucher specimen:
MG-206619). Subsequently, the barks were washed
and dried in an oven with air vent, and triturated in
a knife-mill.
The powder (1.0 kg) was submitted to percolation with
ethanol, followed by concentration in a rotary evaporator
and lyophilization obtaining ethanol extract (168.2 g).
Another part from H. articulatus stem bark powder (100 g)
was submitted to percolation with hydrochloric acid
(1N). The resulting acid solution was alkalized to pH
9 with ammonium hydroxide, affording the partition
with dichloromethane. This solution was concentrated in
a rotatory evaporator, obtaining the dichloromethane
extract (0.32 g) [23].
The ethanol extract (20.00 g) was solubilized with
dichloromethane and subjected to a reflux system (20 min).
Then filtered, and the precipitate was subjected to a
procedure similar to ethyl acetate and methanol [24].
The solutions were concentrated in a rotary evaporator,
and it was obtained dichloromethane (2.615 g), ethyl
acetate (5.38 g) and methanol (9.98 g) fractions. The
ethyl acetate fraction (3.50 g) was fractionated by silica
gel column (60.0 × 2.5 cm) and eluted with solvents
and mixture of these at increasing polarities (hexane,
dichloromethane, ethyl acetate and methanol). Fraction
6 (3.2 g) was later fractionated in chromatographic
column with silica gel (80 × 2 cm) with solvents at
increasing polarities. Sub-fraction 6-8 (1.01 g of plu-
mieride) underwent spectroscopic analyses (NMR,
LC-UV-MS).
The ethanol extract, fractions and plumieride underwent
evaluation by high performance liquid chromatography
with diode array detector (HPLC-DAD, Waters mod. 2695,
USA), C-18 reverse phase column (5 μm, 125 × 45 mm,
LiChrocart 125-4, Merck, Germany), at 40°C, flow rate of
1mL/min, wavelengths scanning from 220 to 400nm. As
mobile phase, a linear gradient of 5% (acetonitrile) and 95%
(aqueous solution of phosphoric acid 0.1% v/v) at time 0
and 65 min with 95% (acetonitrile) and 5% (aqueous
solution of phosphoric acid 0.1% v/v) were used. For
the dichloromethane fraction, the initial gradient was
acetonitrile 90% and aqueous solution 10% of phosphoric
acid 0.1% v/v, 10 to 30 minutes, followed by 80% of aceto-
nitrile and 20% aqueous solution of phosphoric acid 0.1%
v/v from 30 to 32 minutes. Finally, 50% of acetonitrile and
50% aqueous solution of phosphoric acid 0.1% v/v were
used henceforth.
The following spectroscopy methods were used for
structural identification: Ultra High Performance Liquid
Chromatography coupled to UV and Mass Spectrometry
by Electron Spray Ionization (UPLC-PDA-MS/ESI Acquity
H-Class Core System® Waters, USA), 1H NMR, 13C NMR
and DEPT 135 (Bruker NMR spectrometer Advance DPX200, Bruker, USA). The positive mode was used to obtain
electron spray ionization mass spectrometry (Acquity
H-Class Core System® Waters, USA), with capillary
voltage of 3.5 eV, the cone 60eV, CSH130 C-18 column
(particles of 1.7 μm, 50 × 3 mm), flow of 0.3 mL/min,
temperature of 40°C and UV detection between 220 and
400 nm. As mobile phase, a linear gradient was used, in
which the initial time contained aqueous solution of
formic acid 0.1% (A) and acetonitrile with formic acid
0.1% (B), in 10 min 5% of A and 95% B. The NMR used
deuterated methanol (Merck, Germany).
Cytotoxicity assay
The cell viability was determined by the MTT (3- (4,5-
dimethyltrazol-2-yl)-2,5-diphenyl tetrazolium bromide)
method according to Mosman [25]. HepG2 A16 cells
(4x105 cells/0.1 mL) were grown in RPMI-1640 (Roswell
Park Memorial Institute 1640) medium (Sigma Aldrich®,
USA), supplemented with 5% of foetal calf serum, kept in
a 5% CO2 atmosphere at 37°C. The ethanol extract from
H. articulatus was solubilized in RPMI-1640 and dimethyl
sulphoxide (0.02%, v/v). After 24 h, the solution was added
at different concentrations (in μg/mL: 1, 10, 100, 1000),
followed by 24 hours of further incubation. The MTT (2.0
mg/mL) was added, followed by incubation at 37°C in an
atmosphere of 5% CO2 for 4 hours. Dimethyl sulphoxide
was added to each well, and the reactions were mixed to
solubilize the formazan crystals. The optical density was
determined at 570 nm and 630 nm to measure the
signal and background, respectively (Stat Fax 2100
microplate reader, Awareness Technology, Inc., USA).
The cell viability was expressed as a percentage of
the control absorbance in the untreated cells after
subtracting the appropriate background and the average
cytotoxic concentration (CC50) was determined by linear
regression.
Evaluation of anti-plasmodial activity in vitro
Plasmodium falciparum (strain W2) was grown according
to Trager and Jensen [26], synchronized with 5% sorbitol
[27]. Evaluation of in vitro anti-malarial activity was
performed by the quantification of parasitic enzyme
lactate dehydrogenase (pLDH), [28,29]. The test used the
trophozoite stage (parasitaemia of 2% and haematocrit of
1%) and different concentrations of test samples (in μg/mL:
50.00, 25.00, 12.50, 6.25 and 1.56). Normal not infected red
blood cells (RBCs) were used as negative control and as
positive control, parasitized- and non-treated RBCs.
Chloroquine was used as a standard anti-malarial drug.
After 48h of incubation under CO2, plates were frozen
(twice) to promote cell lysis. Fifteen μL of lysate was added
to Malstat reagent (100 μL) and NBT/FT (25 μL), followed
by incubation (1h at 37°C) under light and subsequent
reading at 540 nm. Cell viability (%) was calculated as the
Table 1 Yield and anti-plasmodial activity of samples





DCME Ha 0.2 22.90 ± 0.20
PLUMIERIDE 24.3 >50.00
Cloroquine - 0.15 ± 0.06
EEHa-ethanol extract from Himatanthus articulatus stem bark; FrDCM-
dichloromethane fraction obtained from ethanol extract of Himatanthus
articulatus bark; FrAcOET- ethylacetate fraction obtained from ethanol extract
of Himatanthus articulatus bark; FrMeOH-methanol fraction obtained from
ethanol extract of Himatanthus articulatus bark; DCME Ha - dichloromethane
extract obtained from Himatanthus articulatus bark powder; PLUMIERIDE-iridoid
compound isolated from FrAcOET; Cloroquine-positive control.
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(0% viables) RBCs. The IC50 was determined by means of
linear regression curve.
Evaluation of acute oral and subchronic toxicity
Male (n = 8) and female (n = 8, nulliparous and non-
pregnant) albino Swiss mice, weighing 25-27g, obtained
from the animal facility of the Instituto Evandro Chagas,
(IEC), Ananindeua, Pará, Brazil, were kept in the vivariumFigure 2 Chromatograms profiles: A: EEHa (ethanol extract from Hima
fraccion obtained from ethanol extract of Himatanthus articulatus stem
extract of Himatanthus articulatus stem barks); D: FrMeOH (methanol fr
stem barks); E: PLUMIERIDE (iridoid compound isoled from FrAcOE
Himatanthus articulatus stem barks).of the Faculty of Pharmacy (UFPA) under controlled
temperature and humidity, light and dark cycle of 12 h
each, with pelleted food and filtered tap water ad libitum.
They were daily submitted, weighed, and assessed for food
and water intake. At the end of the experiment, animals
were anesthetized and euthanized, samples of blood were
drawn and target organs were removed for anatomo- and
histopathological evaluation (liver, kidneys, pancreas,
brain and heart) [30,31]. The following laboratory
tests (in sub-chronic test) were performed: complete
blood count, liver function tests, total proteins, albumin,
uric acid, urea, cholesterol, triglycerides [31] and hepatic
lipid peroxidation (TBARS method).
For the acute oral toxicity test, it was used the Fixed
Procedure Test, according to the guideline from OECD
[30], with minor modifications. The animals were submit-
ted to treatment by a single dose (5,000 mg/kg; gavage)
and were evaluated by the Hippocratic test during 14 days.
For the sub-chronic toxicity test, animals were treated
with extract (200 mg/kg and 100 mg/kg each group) for
38 days and a satellite group was maintained for a
further 14 days without treatment [31]. All procedures
were in accordance to the ethical principles of Animal
Experimentation, and the study was approved by the
Ethics Committee (CEPAN /IEC/SVS/MS) under report
number 045/2009.tanthus articulatus stem barks); B: FrDCM (dichloromethane
barks); C: FrAcOET (ethylacetate fraction obtained from ethanol
action obtained from ethanol extract of Himatanthus articulatus
T); F: DCME Ha (dichloromethane extract obtainded from
Table 2 1H and 13C data for plumieride
Position δH ppm (200 MHz) δC ppm (200 MHz)






1 5.3 (d) 5.5 (d) 94.2 93.5
3 7.5 (s) 7.6 (s) 152.6 152.7
4 - - 111.1 111.1
5 - - 40.4 38.8
6 6.4 (dd) 6.7 (dd) 141.5 143.3
7 5.5 (dd) 5.7 (dd) 130.0 129.1
8 - - 97.9 97.6
9 3.2 (dd) 3.2 (dd) 50.6 46.4
10 7.4 (s) 7.6 (s) 150.3 152.7
11 - - 138.6 139.3
12 - - 172.8 174.6
13 - - 63.6 63.6
14 1.4 (d) 1.6 (d) 22.5 22.4
15 - - 168.5 170.4
16 3.7 (s) 3.9 (s) 52.1 53.6
1’ 4.7 (d) 4.9 (d) 100.1 99.8
2’ 2.9 (m) 3.9 (m) 74.7 74.3
3’ 3.5 (m) 3.4 (m) 77.8 77.3
4’ 4.5 (dd) 4.0 (m) 71.3 71.2
5’ 3.8 (m) 3.6 (m) 78.9 78.0
6’ 3.4 (m) 4.0 (m) 62.6 62.4
d-doublet, dd-double doublet, s-singlet, m-multiplet.
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The anti-malarial activity was performed as established
by Peters [32], with modifications. Swiss albino male
mice (n = 10) were 10 days orally pre-treated with the
ethanol extract (200 mg/kg), followed by subsequent
infection with P. berghei. New treatment (200 mg/kg)
was performed for 5 days. On the 5th day after the
infection, blood samples were drawn, animals were
anesthetized for euthanasia and brain and lungs were
removed for evaluation of TEAC (Trolox® Equivalent
Antioxidant Capacity), NN (Nitrite and Nitrate) and
TBARS (Thiobarbituric Acid Reactive Substances). Animals
(n = 10) treated with filtered tap water under the same
conditions as their counterparts in the treated group were
used as a negative control.
Determination of the TEAC was performed according to
Miller et al. [33]. Lipid peroxidation was assessed by the
measurement of the TBARS, according to Percário et al.
[34]. The levels of NN were assayed by the Griess
method [35], using the nitrate/nitrite colourimetric assay
kit (Cayman Chemical Co., USA)
Statistical analysis
For cytotoxicity and anti-plasmodial assay it was used
linear regression. For acute oral toxicity, oxidative
parameters and antioxidant defenses it was applied the
Student t-test for non-paired data, with a significance level
set at p < 0.05. For sub-chronic toxicity it was used
analysis of variance (ANOVA), followed by Tukey's post
hoc test (p < 0.05).
Results and discussion
Phytochemical analysis
The lyophilized ethanol extract from H. articulatus stem
barks was fractionated by re-extraction under reflux yield-
ing three fractions: the dichloromethane, the ethyl acetate
and the methanol fractions (Table 1). The ethyl acetate
fraction presented an HPLC-DAD profile (Figure 2C)
suggestive of iridoids and, therefore, it was submitted
to further fractionation affording sub-fraction 6-8
which was spectroscopically (UV, 1H NMR,13C NMR,
DEPT 135 and MS) characterized as plumieride (Table 2
and Figure 3), the major iridoid found in this plant
species [19,20,36].
HPLC-DAD analysis of ethanol extract and fractions
(Figure 2) showed the presence of peaks of compounds
with high polarity. In all samples, except for the alkaloid
fraction (Figure 2F), there is a predominant peak (retention
time = 8.9 minutes) and an UV spectrum suggestive of iri-
doid chromophore [37]. This hypothesis was strengthened
by injection of plumieride whose retention time and UV
spectra were identical (Figures 2A, C, D and E). Due to low
yield of fractions and plumieride, in vivo studies were not
possible to be performed.Himatanthus articulatus belongs to the Apocynaceae
family, which is known to produce alkaloids [38]. However,
previous studies have not yet described the isolation of al-
kaloids in this species [20,39]. Possibly, this class of
natural products is a minor constituent in H. articulatus,
if present at all. To address this question, a selective
extraction for alkaloids was performed. The resulting
dichloromethane extract showed three major peaks in
the HPLC-DAD (Figure 2F). The UV spectrum of the
most intense one showed λmax = 235 and 273 nm. Due to
the low yield (0.16%) of this extract no compound could
be isolated. However, analyses by UPLC-UV-MS/ESI have
shown that as the major constituent, showing a peak at
RT = 7.91 min (52.83% area; Figure 2F) and a pseudo
molecular ion [M+ 1] = 329 u. Moreover, due to the low
quantity of dichloromethane extract available, in vivo
studies were not performed.
The chromatography study showed chemical similarity
between the ethanol extract and its fractions (Figure 2).
Currently, animal testing should be conducted in
compliance with the principle of the 3Rs (reduction,
refinement and replacement) [40]. As the ethanol extract
has chemical similarities with all its fractions, it was
Figure 3 Mass spectrum of plumieride registered online by UPLC-UV-MS/ESI showing pseudomelecular ion and fragments derived from it.
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extract only. Thus, there was a significant reduction
of the number of animals used.
Anti-malarial activity
All samples were submitted to anti-plasmodial activity
evaluation by the pLDH method [28,29]. The ethanol
extract, its fractions and plumieride were inactive
against the chloroquine-resistant P. falciparum W2 clone
(Table 1). Another iridoid (8-THE-acetylharpagide) also
proved to be inactive against chloroquine-sensitive P.
falciparum [41]. Collectively, these results suggest iridoid-
rich extracts are inactive. Nevertheless, in vivo studies are
still needed and deserve to be investigated. By contrast, the
dichloromethane extract proved to be active against this
clone (IC50 = 22.9 ± 0.2 μg/mL; Table 1).
The barks of H. articulatus are widely used for malaria
treatment in the Amazon traditional medicine [9],
suggesting the hypothesis that this species might interferein the pathogenesis of the disease. Therefore, the ethanol
extract was subjected to in vivo studies against P. berghei-
infected mice when parasitaemia and oxidative parameters
were evaluated (TBARS, TEAC and NN).
Further, contrarily to the in vitro study, the ethanol
extract significantly reduced parasitaemia by 35.4% at
a dose of 200 mg/kg. Plant extracts in which the reduction
of parasitaemia is greater than 30% are considered active
[42]. Several factors may be influencing this divergence of
results amongst them: differences between the parasites
used in the studies, or perhaps the extract contains a sub-
stance that requires prior hepatic metabolism to become
active [43].
In addition, the mechanisms that trigger the respiratory
distress present in pulmonary malaria are multifactorial.
There is an evidence of the involvement of free radicals
affecting cell membranes, attacking the endothelium and
changing the vascular permeability [44]. An important
mediator of this process seems to be nitric oxide [45].
Table 3 Oxidative stress parameters of mice from both groups
Groups NN (μM) TBARS (μg/L) TEAC (mM/L)
Brain Lung Brain Lung Brain Lung
Infected 507.3 ± 52.2 408.8 ± 49.1 224.8 ± 66.2 86.9 ± 40.5 20.0 ± 3.4 11.0 ± 3.3
EEHa 315.8 ± 57.0* 257.8 ± 48.0* 258.2 ± 57.7NS 38.0 ± 16.2* 21.5 ± 5.2NS 6.1 ± 9.6NS
Values are presented as mean ± standard deviation (n = 10 animals). Infected Group: Plasmodium berghei-infected mice; EEHa: Plasmodium berghei-infected mice
and treated with EEHa (ethanol extract from Himatanthus articulatus stem bark) 200 mg/Kg, orally. NN: nitrite/nitrate; TBARS: thiobarbituric acid reactive
substances; TEAC: Trolox® Equivalent Antioxidant Capacity. *p < 0.05 versus Infected Group. NSNon-significant versus Infected Group. Student’s. “t” Test.
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of parasitized erythrocytes to human pulmonary endothe-
lium may be regulated by TNF, cytokine that induces the
expression of iNOS enzymes, suggesting that the inhibition
of NO synthesis may indeed protect pulmonary endothelial
cells. Additionally, Dimmeler et al. [47] observed that iNOS
inhibition by N-monomethyl-L-arginine (L-NMMA)
impairs TNF induced endothelial cells apoptosis and,
therefore, might be a protective mechanism.
In the present study, a significant decrease in the levels
of brain and pulmonary nitrite and nitrate was observed
(Table 3). These data suggest that the ethanol extract of
H. articulates plays an inhibitor role upon NO synthesis
and/or decreases NO concentration by directly scavenging
it, thus potentially protecting the respiratory epithelium
and reducing the severity of the respiratory distress to the
animals.
In parallel, the TBARS assesses the intensity of lipid
peroxidation, which contributes to the inflammatory
reaction due to the activation of pro-inflammatory
cytokines, such as lymphotoxin and TNF) and IL-8.
The reduction in TBARS levels found in the lungs of
infected- and treated-animals (Table 3) may indicate a
reduction of pulmonary inflammation and, possibly,
an additional effect of NO decreased synthesis or of
antioxidants present in the extract. In fact, in spite of
no differences in TEAC values were seen between groups,Table 4 Hematological values of 38 days EEHa-treated mice
Hematological
parameters
Males (n = 8)
C T200 T100 S
WBC (103/mm3) 6.0 ± 1.6 10.0 ± 2.8 10.0 ± 1.6 7.9 ±
RCB (106/mm3) 6.5 ± 2.3 7.4 ± 0.7 7.8 ± 0.5 7.8 ±
Hb (g/dL) 12.1 ± 3.9 11.8 ± 1.3 12.9 ± 0.6 12.9 ±
Hem (%) 35.8 ± 1.1 35.1 ± 2.6 39.2 ± 0.9 39.6 ±
MCV (fL) 48.6 ± 1.6 49.1 ± 0.7 49.4 ± 0.9 50.5 ±
MCH (pg) 16.5 ± 1.1 16.0 ± 0.6 16.4 ± 0.7 16.3 ±
HCMC (g/dL) 33.6 ± 1.1 32.4 ± 0.6 32.9 ± 0.5 32.4 ±
Plat (103/mm3) 244.5 ± 63.0 445.3 ± 74* 403.0 ± 53.7 400.0
EEHa: Ethanol extract from Himatanthus articulatus stem bark; WBC- white blood ce
MCV- mean corpuscular volume; HCM- mean corpuscular hemoglobin; CHCM- mean
T200- group treated orally with EEHa (200 mg/Kg); T100- group treated orally withit is possible to state that the ethanol extract may have
some antioxidant properties, as several iridoids are regarded
as antioxidant molecules [48,49].
In relation to brain findings, despite the reduction of
nitrite and nitrate levels, no differences for TBARS and
TEAC were found between groups. These results may
indicate that the blood brain barrier could prevent the
passage of certain constituents of the extract. Another
possibility lies on the high cholesterol content of
neuronal cells, as they are suitable to intense lipid
peroxidation, whose might have surpassed the potential
antioxidant effects of the extract.
In summary, the ethanol extract of H. articulatus reduced
parasitaemia in P. berghei-infected mice. This extract also
significantly interfered in oxidative parameters related to
the pathogenesis of malaria. These results leads us to the
following thought: when a plant species, of broad popular
use for malaria, produces negative results in in vitro assays,
in vivo studies ought to be performed. Such in vivo experi-
ments should ascertain both clinical and parasitological
aspects of the disease. Only then is it possible to validate
anti-malarial activity of a certain natural product.
Toxicity studies
Due to significant anti-malarial activity of the ethanol
extract, cytotoxicity, acute in vivo and sub-chronic
toxicity evaluations were performed. The ethanol extractFemales (n = 8)
C T200 T100 S
3.0 4.6 ± 0.4 5.4 ± 1.5 6.3 ± 1.4 14.5 ± 2.1*
0.7 5.0 ± 0.6 5.1 ± 0.8 7.6 ± 0.3* 7.9 ± 0.5*
1.4 7.8 ± 1.1 8.3 ± 0.9 13.0 ± 0.7* 13.3 ± 0.9*
4.0 24.0 ± 2.5 25.2 ± 3.2 39.3 ± 1.5* 40.8 ± 2.5*
0.6 48.3 ± 0.7 48.8 ± 1.4 52.0 ± 0.5* 51.5 ± 0.6*
0.4 15.8 ± 0.7 15.9 ± 0.6 16.9 ± 0.7 16.8 ± 0.3
0.4 31.8 ± 0.5 32.7 ± 0.5 32.9 ± 0.7* 32.6 ± 0.5
± 145.1 283.3 ± 7.8 207.0 ± 43.4 346.0 ± 49.5 403.3 ± 161
ll count; RCB- red blood cell count; Hb- hemoglobin; Hem- hematocrit;
corpuscular hemoglobin concentration; Plat- platelets; C- control group;
EEHa (100 mg/Kg); S- satellite group. *p < 0.05 versus control group.
Figure 4 Liver thiobarbituric acid reactive substances (TBARS)
values from 38 days EEHa-treated mice. C- control group;
T200- group treated orally with EEHa (200 mg/Kg); T100- group
treated orally with EEHa (100 mg/Kg); S- satellite group. *p < 0.05
versus control group (8 animals/group).
Table 5 Laboratory patterns of 38 days EEHa-treated mice
Laboratory
Parameters
Males (n = 8) Females (n = 8)
C T200 T100 S C T200 T100 S
AST (UI/L) 136.7 ± 52.3 111.0 ± 56.6 147.0 ± 59.6 82.2 ± 17 83.5 ± 6.4 124.0 ± 18.4 * 65.0 ± 32.4 88.3 ± 19.5
ALT (UI/L) 7.7 ± 2.9 8.2 ± 1.7 7.5 ± 1.3 8.2 ± 2.1 16.0 ± 1.4 7.0 ± 1.4* 6.0 ± 0.0 * 6.4 ± 0.9*
ɣGT (UI/L) 11.5 ± 10.6 4.0 ± 0.0 4.2 ± 0.4 4.0 ± 0.0 4.0 ± 0 4.3 ± 0.6 4.0 ± 0.0 4.0 ± 0.0
Alb (g/dL) 2.9 ± 0.4 2.3 ± 0.2 * 2.6 ± 0.1 2.4 ± 0.2 3.4 ± 0.9 2.4 ± 0.5 2.4 ± 0.4 2.4 ± 0.2
TP (g/dL) 6.4 ± 2,35 4.2 ± 0.2* 4.3 ± 0.1 4.5 ± 0.4 4.7 ± 0.6 3.6 ± 0.7 3.9 ± 0.3 4.7 ± 0.3
TC (mg/mL) 95.0 ± 15.4 83.7 ± 3.2 86.0 ± 4.2 86.7 ± 4.3* 99.3 ± 10.0 66.6 ± 7.6* 83.5 ± 5.8 67.3 ± 3.2*
TGD (mg/mL) 163.0 ± 31.1 205.7 ± 15.0* 185.3 ± 12.7 229.7 ± 2.5* 173.3 ± 17.8 132.5 ± 17.7 154.0 ± 12.1 163.8 ± 18,5
EEHa: Ethanol extract from Himatanthus articulatus stem bark; AST-aspartate aminotransferase; ALT-alanine aminotransferase; ɣGT- gamma glutamyl transferase;
Alb- albumin; TP- total protein; TC- Total cholesterol; TGD- triglycerides; Ur- urea; UA- uric acid; C- control group; T200- group treated orally with EEHa (200 mg/Kg);
T100- group treated orally with EEHa (100 mg/Kg); S- satellite group. *p < 0.05 versus control group.
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A16 cells in the concentrations used (CC50 > 1000 μg/mL).
Nevertheless, in addition to the assessment of toxicity in
cell lines, it is important to evaluate the oral acute and
sub-chronic toxicity of the active sample in mammals.
The group of mice acutely treated orally with a high dose
of the extract (5,000 mg/kg) showed neither immediate, nor
during the observation period (14 days) clinical changes.
No deaths occurred in the period of the experiment and no
anatomopathological changes were observed in the organs
evaluated. Besides, the differences between the sexes did
not influence toxicity results.
Another study evaluated the acute toxicity of the extract
from leaves of H. drasticus, with the animals showing
signs of excitability, agitation and increased respiratory
rate (dose = 2,000 mg/kg) [50]. Nevertheless, neither
histopathological changes, nor other signs of toxicity
were observed, suggesting that species of the genus
Himatanthus have low acute toxicity.
No clinical changes or in water/chow intake were
observed in the groups treated with the ethanol extract
of H. articulatus. However, significant changes were ob-
served on haematological and biochemical parameters
(Tables 4 and 5).
In the present study, haematological alterations were
observed only in females, even in the group treated with
the lowest dose (Table 4). At a dose of 100 mg/kg in
females, the following changes were observed: increases in
red blood cell-count, haemoglobin, haematocrit, MCV and
MCHC (Table 4). The elevations of MCV and MCHC sug-
gest macrocytosis and this should be investigated. In
addition, there was an increase in the number of platelets
and leukocytes. However, at the highest dose, these changes
were only observed in the satellite group (Table 4).
It is known that females are more vulnerable to adverse
drug reactions, as well as its toxic effects. Perhaps, the hor-
mones related to this gender change significantly the phar-
macokinetic aspects. These changes, perhaps, might have
contributed to the vulnerability to toxic hematologicaleffects. The biochemical changes occurred in both genders,
being that in males it was seen at the highest dose (200
mg/kg). The reduction of albumin and total protein may
be related to the inhibition of hepatic protein synthesis.
Nevertheless, this inhibition is possibly reversible, as it has
not been observed in the satellite group (Table 5).
Other changes observed in males included: increase of
triglycerides and a reduction in uric acid levels (Table 5).
The increase of uric acid synthesis has been related to
increased antioxidant activity. It is also a marker of the
ischemia-reperfusion syndrome [51]. In the present study,
the decrease of uric acid may suggest a lesser extent of
ischemic events than in the control group. In the group of
male animals, treated with 200 and 100 mg/kg of extract,
a significant reduction of hepatic TBARS was observed.
On the other hand, in the group of females TBARS levels
were significantly increased (Figure 4). TBARS is a widely
used lipid peroxidation marker and its increase can
Vale et al. Malaria Journal  (2015) 14:132 Page 9 of 10suggest high rate of cell membrane damage, while the
reduction in male can signal the reduction of damage.
As stated earlier, changes in pharmacokinetic properties,
and in particular in the metabolism, might justify the
differences in the responses amongst genders.
Conclusion
An extract from H. articulatus bark containing plumieride
as the major constituent. The ethanol extract from H.
articulatus stem barks, although inactive in vitro (against P.
falciparum), showed activity against P. berghei in an in vivo
study. The ethanol extract may contain a substance that
after metabolism becomes active. Another relevant fact
found in the present study was the safety of this extract.
The ethanol extract showed low cytotoxicity (IC50 > 1000
mg/mL), causing no significant clinical changes both in
acute and sub-chronical administration. Besides, no histo-
pathological changes were observed. Only biochemical and
haematological reversible changes were observed. This study
attested some anti-malarial activity of the H. articulatus
extracts, as well as its safety, thus validating its popular use.
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